Frost Radar™: Artificial Intelligence for Healthcare IT, Global, 2020
Benchmarking Future Growth Potential
02-Jun-2020
Global
Frost Radar
K4D8-01-00-00-00
HC03299-GL-MR_24433
$4,950.00
Special Price $3,712.50 save 25 %
Frost & Sullivan research has identified the core areas in which artificial intelligence (AI)-enabled healtchcare IT solutions are most relevant for hospitals, physicians, and payers.
Hospitals that have so far invested in AI-based financial solutions to automate patient access management, reimbursement eligibility matching, and computer-assisted coding are now also preferring clinical-grade AI solutions for imaging analytics, genomics profiling, clinical risk stratification, and precision medicine-based diagnosis.
Physician practices continue to focus on automated, AI-based healthcare IT solutions that perform practice management, physician scheduling, and workforce attribution. Large group practices are investing in conversational AI solutions that engage and activate patients via chatbot. AI also allows practice management software to merge with a third-party electronic medical record (EMR) or population health management platform for effective referral management and patient tracking in their journey across the care continuum.
The payer market, one of the biggest investors in AI-based healthcare IT solutions, is betting big on enterprise-grade AI platforms that predict epidemics (such as COVID-19), forecast patient volume across their member providers, authenticate reimbursement, and drive general well-being of the insured population through medication management and self-care enablement.
Other stakeholders are emerging, too. Government agencies, patients, incubators, academic medical centers, large healthcare IT vendors, and institutional investors are playing important roles in helping this technology gain traction in global healthcare market.
The Frost Radar™ reveals the market positioning of companies in an industry using their Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each of the companies in the Frost Radar™ based on their strengths, opportunities, and a small discussion on their positioning. Frost & Sullivan analyzes hundreds of companies in the industry and benchmarks them across 10 criteria on the Frost Radar™, where the leading companies in the industry are then positioned. Industry leaders on both the Growth and Innovation indices are recognized as best practice recipients.
Author: Koustav Chatterjee
Strategic Imperative
Strategic Imperative (continued)
Growth Environment
Frost Radar™
Frost Radar™
Frost Radar™
Frost Radar™
Allscripts
Amazon Web Services
Apple
Change Healthcare
GE Healthcare
Health Catalyst
HP Systems
IBM Watson Health
Inovalon
Intel
Medial Early Sign
Microsoft
Nuance
Optum
Philips Healthcare
Qure.ai
Salesforce
SigTuple
Wolters Kluwer
Strategic Insights
Significance of Being on the Frost Radar™
Frost Radar™ Empowers the CEO’s Growth Team
Frost Radar™ Empowers Investors
Frost Radar™ Empowers Customers
Frost Radar™ Empowers the Board of Directors
Frost Radar™: Benchmarking Future Growth Potential
Frost Radar™: Benchmarking Future Growth Potential
Frost Radar™: Benchmarking Future Growth Potential
Legal Disclaimer
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform
Growth Index
Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.
-
Market Share (previous 3 years)
This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years. -
Revenue Growth (previous 3 years)
This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™. -
Growth Pipeline
This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities. -
Vision and Strategy
This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision? -
Sales and Marketing
This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.
Innovation Index
Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.
-
INNOVATION SCALABILITY
This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals. -
RESEARCH AND DEVELOPMENT
This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline. -
PRODUCT PORTFOLIO
This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue. -
MEGATRENDS LEVERAGE
This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline. -
CUSTOMER ALIGNMENT
This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.
Significance of Being on the Frost Radar™
Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.
-
GROWTH POTENTIAL
Your organization has significant future growth potential, which makes it a Company to Action. -
BEST PRACTICES
Your organization is well positioned to shape Growth Pipeline™ best practices in your industry. -
COMPETITIVE INTENSITY
Your organization is one of the key drivers of competitive intensity in the growth environment. -
CUSTOMER VALUE
Your organization has demonstrated the ability to significantly enhance its customer value proposition. -
PARTNER POTENTIAL
Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.
Speak directly with our analytics experts for tailored recommendations.
Recent related Digital Health research
06 Aug 2026 | Global | Technology Research
Decentralized Clinical Trials Powered by Blockchain and Digital Twins
This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...
30 Jul 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026
The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...
22 Jul 2026 | Global | Market Research
Healthcare Cybersecurity, Global, 2026–2031
The global healthcare cybersecurity market is entering a new phase of growth as cyber risk becomes directly linked to patient safety, care continuity, and operational resilience. Healthcare organizations are expanding digital infrastructure across cloud environments, connected medical devices, patie...
17 Jul 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age...
15 Jul 2026 | North America | Frost Radar
Frost Radar™: Clinical Ambient AI in North America, 2026
This Frost Radar™ analyzes the clinical ambient AI solutions that enable clinicians to improve their efficiency at the point of care. AI scribe capability has become the baseline market requirement, eliminating it as a differentiator and pushing vendors to compete on higher-order clinical and fina...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Frost Radar |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Koustav Chatterjee |
| Industries | Healthcare |
| WIP Number | K4D8-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9612-B1 |